Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cumberland Pharmaceu (CPIX)

Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,349
  • Shares Outstanding, K 14,957
  • Annual Sales, $ 37,870 K
  • Annual Income, $ -6,480 K
  • EBIT $ 1 M
  • EBITDA $ 6 M
  • 60-Month Beta -0.58
  • Price/Sales 1.18
  • Price/Cash Flow 13.69
  • Price/Book 2.04

Options Overview Details

View History
  • Implied Volatility 470.24% (+206.60%)
  • Historical Volatility 90.65%
  • IV Percentile 89%
  • IV Rank 43.58%
  • IV High 1,000.24% on 08/12/25
  • IV Low 60.88% on 11/20/25
  • Expected Move (DTE 11) 0.09 (2.74%)
  • Put/Call Vol Ratio 1.58
  • Today's Volume 137
  • Volume Avg (30-Day) 140
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 2,646
  • Open Int (30-Day) 2,543
  • Expected Range 3.32 to 3.50

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.30 +3.33%
on 03/09/26
5.03 -32.21%
on 03/02/26
-0.44 (-11.43%)
since 02/09/26
3-Month
2.28 +49.56%
on 12/10/25
5.38 -36.62%
on 01/07/26
+1.15 (+50.88%)
since 12/09/25
52-Week
1.85 +84.32%
on 11/18/25
6.39 -46.64%
on 03/10/25
-2.96 (-46.47%)
since 03/07/25

Most Recent Stories

More News
Cumberland: Q4 Earnings Snapshot

Cumberland: Q4 Earnings Snapshot

CPIX : 3.41 (-2.57%)
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH

Cumberland to highlight 2025 financial, international, portfolio and clinical progress

CPIX : 3.41 (-2.57%)
Joint U.S. Commercialization of RedHill's Talicia® Commences

The full sales and operational launch of Talicia, under the joint commercialization agreement between Talicia Holdings Inc. (THI), a jointly controlled entity of RedHill and Cumberland has started and...

RDHL : 0.9241 (+0.45%)
CPIX : 3.41 (-2.57%)
CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®

NASHVILLE, Tenn. , Feb. 25, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused on developing new products for rare diseases, today...

CPIX : 3.41 (-2.57%)
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE

NASHVILLE, Tenn. , Feb. 24, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that it will release its 2025 financial results...

CPIX : 3.41 (-2.57%)
Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program

NASHVILLE, Tenn. , Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused on developing new products for rare diseases, announced...

CPIX : 3.41 (-2.57%)
CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT

NASHVILLE, Tenn. , Dec. 8, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), today announced an important update regarding its Caldolor ® (ibuprofen) Injection. The product's...

CPIX : 3.41 (-2.57%)
Cumberland: Q3 Earnings Snapshot

Cumberland: Q3 Earnings Snapshot

CPIX : 3.41 (-2.57%)
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH

NASHVILLE, Tenn. , Nov. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved...

CPIX : 3.41 (-2.57%)
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE

NASHVILLE, Tenn. , Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that it will release its third quarter 2025...

CPIX : 3.41 (-2.57%)

Business Summary

Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in...

See More

Key Turning Points

3rd Resistance Point 3.79
2nd Resistance Point 3.67
1st Resistance Point 3.54
Last Price 3.41
1st Support Level 3.29
2nd Support Level 3.17
3rd Support Level 3.04

See More

52-Week High 6.39
Fibonacci 61.8% 4.66
Fibonacci 50% 4.12
Fibonacci 38.2% 3.58
Last Price 3.41
52-Week Low 1.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar